Awards & Advancement

Celgene announces exec changes, including Hugan and executive chairman

Tuesday, January 12, 2016

Celgene has announced organizational changes that will position the company for continued long-term growth, effective March 1. Bob Hugin will serve as executive chairman. Hugin will continue to lead the board of directors and manage the strategic direction of the company. Mark Alles will be promoted to chief executive officer. Jacqualyn Fouse, Ph.D., will be promoted to president and chief operating officer. Scott Smith, president of immunology and inflammation, will assume an expanded leadership role.

[Read More]

Aegerion appoints Mary Szela CEO

Monday, January 11, 2016

Aegerion Pharmaceuticals, a biopharmaceutical company dedicated to the development and commercialization of innovative therapies for patients with debilitating rare diseases, has appointed Mary Szela as chief executive officer and a member of Aegerion’s board of directors. Szela brings 27 years of progressive leadership experience to Aegerion as well as valuable expertise building global billion-dollar brands, such as Humira, and advancing pipeline products in the biotechnology and pharmaceutical industries.

[Read More]

Valeant names Schiller Interim CEO

Thursday, January 7, 2016

Valeant Pharmaceuticals International has appointed Howard Schiller interim chief executive officer of Valeant, effective immediately. Schiller was Valeant’s chief financial officer from December 2011 through June 2015 and currently serves on Valeant’s board of directors. Valeant also announced that Robert Ingram, lead independent director, will serve as interim chairman of the board of directors.

[Read More]

Merck wins innovation award from R&D Magazine

Wednesday, December 16, 2015

Merck, a Germany-based science and technology company, has received two R&D Magazine 100 awards—one for its lab water purification systems, and the other for a technology that allows researchers to investigate scientific questions they previously couldn’t address.

[Read More]